Announced Sat, 11 Jul · 15:31 IST
Promoters convert warrants, stake rises to 39.35%
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.2%1-day move
₹66.49
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+6.2+6.8+0.0+0.8-0.1+5.3————
Up moveDown movePending
AI summary
Promoter group entities Srinidhi Fine-Chemicals LLP and Narahari Belide converted 25 lakh warrants into equity shares of Novelix Pharmaceuticals on 09 July 2026, raising combined promoter holding from 36.42% to 39.35%. Srinidhi Fine-Chemicals LLP now holds 1,00,02,000 shares (35.13%) and Narahari Belide holds 12,00,000 shares (4.21%). Share capital expanded to Rs 28.47 crore from Rs 23.895 crore.
Likely market impact
Promoter stake rises via warrant conversion, no fresh cash needed. Holding at 39.35%, any future buy crossing 40% trigger would require an open offer.